Role of Pharmacists in Pharmacovigilance and Adverse Drug Reaction Reporting
DOI:
https://doi.org/10.22399/ijcesen.4240Keywords:
Pharmacists, pharmacovigilance, adverse drug reactions, ADR reporting, medication safety, patient consultationsAbstract
Pharmacists play a crucial role in pharmacovigilance, which involves the monitoring, assessment, and prevention of adverse drug reactions (ADRs). As accessible healthcare professionals, pharmacists are often the first point of contact for patients experiencing medication-related issues. They are trained to recognize the signs of ADRs and to understand the complex interactions that can occur with various medications. By actively engaging with patients during consultations, pharmacists can gather valuable information about drug therapy and identify potential safety concerns. Their expertise not only aids in the immediate management of ADRs but also contributes to the broader system of pharmacovigilance by reporting these incidents to regulatory authorities, which can lead to safer medication practices and greater public health outcomes. In addition to their role in identifying and managing ADRs, pharmacists also serve as educational resources for both patients and healthcare providers. They can provide vital information about drug safety, proper usage, and potential side effects, thus empowering patients to take an active role in their health care. Pharmacists can also influence prescribing practices by providing feedback to prescribers about reported ADRs and offering recommendations for alternative therapies when necessary. By maintaining accurate records of ADRs through systematic reporting pathways, pharmacists significantly contribute to database systems that track medication safety and effectiveness, ultimately enhancing drug surveillance and aiding in informed clinical decision-making.
References
[1] Yu YM, Lee E, Koo BS, et al. Predictive factors of spontaneous reporting of adverse drug reactions among community pharmacists. PLoS One. 2016;11(5):e0155517. DOI: https://doi.org/10.1371/journal.pone.0155517
[2] Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients. JAMA. 1998;279(15):1200-1205. DOI: https://doi.org/10.1001/jama.279.15.1200
[3] Glassman P. Clinical pharmacist's role in preventing adverse drug events: brief update review. In: Making Health Care Safer II: An Updated Critical Analysis of the Evidence for Patient Safety Practices. Rockville, MD: Agency for Healthcare Research and Quality; 2013.
[4] Ortega A, Aguinagalde A, Lacasa C, Aquerreta I, Fernández-Benítez M, Fernández LM. Efficacy of an adverse drug reaction electronic reporting system integrated into a hospital information system. Ann Pharmacother. 2008;42(10):1491-1496. DOI: https://doi.org/10.1345/aph.1L130
[5] Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. BMJ. 2004;329(7456):15-19. DOI: https://doi.org/10.1136/bmj.329.7456.15
[6] van Grootheest K, Olsson S, Couper M, de Jong-van den Berg L. Pharmacists' role in reporting adverse drug reactions in an international perspective. Pharmacoepidemiol Drug Saf. 2004;13(7):457-464. DOI: https://doi.org/10.1002/pds.897
[7] Duarte M, Ferreira P, Soares M, Cavaco A, Martins AP. Community pharmacists' attitudes towards adverse drug reaction reporting and their knowledge of the new pharmacovigilance legislation in the southern region of Portugal: a mixed methods study. Drugs Ther Perspect. 2015;31(9):316-322. DOI: https://doi.org/10.1007/s40267-015-0227-8
[8] Mann R, Elizabeth A. Pharmacovigilance. 2nd ed. West Sussex, England: John Wiley & Sons Ltd; 2007.
[9] Bouvy JC, De Bruin ML, Koopmanschap MA. Epidemiology of adverse drug reactions in Europe: a review of recent observational studies. Drug Saf. 2015;38(5):437-453. DOI: https://doi.org/10.1007/s40264-015-0281-0
[10] Calvert RT. Clinical pharmacy—a hospital perspective. Br J Clin Pharmacol. 1999;47(3):231-238. DOI: https://doi.org/10.1046/j.1365-2125.1999.00845.x
[11] Saygi S, Alkas FB, Etikan I, Gelisen I, Sardas S. Pharmacovigilance awareness among the community pharmacists and pharmacy students in the Turkish Republic of Northern Cyprus. J Pharmacovigil. 2016;4:204. DOI: https://doi.org/10.4172/2329-6887.1000204
[12] Green CF, Mottram DR, Rowe PH, Pirmohamed M. Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting. Br J Clin Pharmacol. 2001;51(1):81-86. DOI: https://doi.org/10.1046/j.1365-2125.2001.01306.x
[13] Olsson S. National Pharmacovigilance Systems-Country profiles and Overview. 2nd ed. Uppsala: Uppsala Monitoring Centre; 1999.
[14] Abdel-Latif MMM, Abdel-Wahab BA. Knowledge and awareness of adverse drug reactions and pharmacovigilance practices among health-care professionals in Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia. Saudi Pharm J. 2015;23(2):154-161. DOI: https://doi.org/10.1016/j.jsps.2014.07.005
[15] World Health Organization. International drug monitoring: the role of national centres. Report of a WHO Meeting. Geneva: 1972.
[16] Jose J, Jimmy B, Al-Ghailani ASH, Al-Majali MA. A cross sectional pilot study on assessing the knowledge, attitude and behavior of community pharmacists to adverse drug reaction related aspects in the Sultanate of Oman. Saudi Pharm J. 2014;22(2):163-169. DOI: https://doi.org/10.1016/j.jsps.2013.07.006
[17] Hadi MA, Ming LC. Impact of pharmacist recruitment on ADR reporting: Malaysian experience. South Med Rev. 2011;4(2):102-103. DOI: https://doi.org/10.5655/smr.v4i2.1009
[18] Lynn RM, Riding K, McIntosh N. The use of electronic reporting to aid surveillance of ADRs in children: a proof of concept study. Arch Dis Child. 2010;95(4):262-265. DOI: https://doi.org/10.1136/adc.2009.158766
[19] Rossi AC, Knapp DE, Anello C, et al. Discovery of adverse drug reactions. A comparison of selected phase IV studies with spontaneous reporting methods. JAMA. 1983;249(16):2226-2228. DOI: https://doi.org/10.1001/jama.1983.03330400072029
[20] Schlienger RG, Lüscher TF, Haefeli WE, Schoenenberger RA. Academic detailing improves identification and reporting of adverse drug events. Pharm World Sci. 1999;21(3):110-115. DOI: https://doi.org/10.1023/A:1008631926100
[21] Obara T, Yamaguchi T, Satoh M, et al. Prevalence, determinants and reasons for the non-reporting of adverse drug reactions by pharmacists in the Miyagi and Hokkaido regions of Japan. Adv Pharmacoepidemiol Drug Saf. 2015;4:191.
[22] Suyagh M, Farah D, Abu-Farha R. Pharmacist's knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process. Saudi Pharm J. 2015;23(2):147-153. DOI: https://doi.org/10.1016/j.jsps.2014.07.001
[23] Green CF, Mottram DR, Rowe P, Brown AM. Attitudes of hospital pharmacists to adverse drug reaction reporting: a qualitative survey. Int J Pharmacy Prac. 1999;7(4):247-255. DOI: https://doi.org/10.1111/j.2042-7174.1999.tb00976.x
[24] Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006;29(5):385-396. DOI: https://doi.org/10.2165/00002018-200629050-00003
[25] Pal SN, Duncombe C, Falzon D, Olsson S. WHO strategy for collecting safety data in public health programmes: complementing spontaneous reporting systems. Drug Saf. 2013;36(2):75-81. DOI: https://doi.org/10.1007/s40264-012-0014-6
[26] Elkalmi RM, Hassali MA, Ibrahim MI, Jamshed SQ, Al-Lela OQ. Community pharmacists' attitudes, perceptions, and barriers toward adverse drug reaction reporting in Malaysia: an quantitative insight. J Patient Saf. 2014;10(2):81-87. DOI: https://doi.org/10.1097/PTS.0000000000000051
[27] Khan TM. Community pharmacists' knowledge and perceptions about adverse drug reactions and barriers towards their reporting in Eastern region, Alahsa, Saudi Arabia. Ther Adv Drug Saf. 2013;4(2):45-51. DOI: https://doi.org/10.1177/2042098612474292
[28] Gavaza P, Bui B, Candidate P. Pharmacy students' attitudes toward reporting serious adverse drug events. Am J Pharm Educ. 2012;76(10):1-6. DOI: https://doi.org/10.5688/ajpe7610194
[29] Sweis D, Wong IC. A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain. Drug Saf. 2000;23(2):165-172. DOI: https://doi.org/10.2165/00002018-200023020-00006
[30] Pagotto C, Varallo FR, Mastroianni PC. Impact of educational interventions on adverse drug events reporting. Int J Technol Assess Health Care. 2013;29(4):410-417. DOI: https://doi.org/10.1017/S0266462313000457
[31] Gonzalez-Gonzalez C, Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Strategies to improve adverse drug reaction reporting: a critical and systematic review. Drug Saf. 2013;36(5):317-328. DOI: https://doi.org/10.1007/s40264-013-0058-2
[32] Cullen DJ, Sweitzer BJ, Bates DW, Burdick E, Edmondson A, Leape LL. Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units. Crit Care Med. 1997;25(8):1289-1297. DOI: https://doi.org/10.1097/00003246-199708000-00014
[33] Mahmoud MA, Alswaida Y, Alshammari T, et al. Community pharmacists' knowledge, behaviors and experiences about adverse drug reaction reporting in Saudi Arabia. Saudi Pharm J. 2014;22(5):411-418. DOI: https://doi.org/10.1016/j.jsps.2013.07.005
[34] Roberts PI, Wolfson DJ, Booth TG. The role of pharmacists in adverse drug reaction reporting. Drug Saf. 1994;11:7-11. DOI: https://doi.org/10.2165/00002018-199411010-00002
[35] Al-hazmi NN, Naylor IL. A study of community pharmacists' awareness and contributions to adverse drug reactions (ADRs) reporting systems in the Makkah, Kingdom of Saudi Arabia. J Clin Trials. 2013;3:127. DOI: https://doi.org/10.4172/2167-0870.1000127
[36] Osemene KP, Ayeni MI, Afolabi MO. The role of community pharmacists in monitoring adverse drug reactions in Nigeria. J Pharm Health Serv Res. 2012;3(4):197-204. DOI: https://doi.org/10.1111/j.1759-8893.2012.00100.x
[37] Fontanarosa PB, Rennie D, DeAngelis CD. Postmarketing surveillance – lack of vigilance, lack of trust. JAMA. 2004;292(21):2647-2650. DOI: https://doi.org/10.1001/jama.292.21.2647
[38] Hadi MA, Helwani R, Long CM. Facilitators and barriers towards adverse drug reaction reporting: perspective of Malaysian hospital pharmacists. J Pharm Health Serv Res. 2013;4:155-158. DOI: https://doi.org/10.1111/jphs.12022
[39] Rajiah K, Maharajan MK, Nair S. Pharmacy students' knowledge and perceptions about adverse drug reactions reporting and pharmacovigilance. Saudi Pharm J. 2016;24(5):600-604. DOI: https://doi.org/10.1016/j.jsps.2015.03.021
[40] Liu J, Zhou Z, Yang S, et al. Factors that affect adverse drug reaction reporting among hospital pharmacists in Western China. Int J Clin Pharm. 2015;37(3):457-464. DOI: https://doi.org/10.1007/s11096-015-0065-8
[41] Lexchin J. Is there still a role for spontaneous reporting of adverse drug reactions? CMAJ. 2006;174(2):191-192. DOI: https://doi.org/10.1503/cmaj.050971
[42] Qassim S, Metwaly Z, Shamsain M, Al-Hariri Y. Reporting adverse drug reactions: evaluation of knowledge, attitude and practice among community pharmacists in UAE. IOSR J Pharm. 2014;4:17-23. DOI: https://doi.org/10.9790/3013-040417-23
[43] Rabba AK, Mohammad R. Pharmacovigilance Study: Exploring the Role of Community Pharmacists in Adverse Drug Reactions Reporting in Alkharj City, Saudi Arabia. Lat Am J Pharm. 2015;34(5):901-906.
[44] Elkalmi RM, Hassali MA, Ibrahim MI, Widodo RT, Efan QM, Hadi MA. Pharmacy students' knowledge and perceptions about pharmacovigilance in Malaysian public universities. Am J Pharm Educ. 2011;75(5):96. DOI: https://doi.org/10.5688/ajpe75596
[45] Farha RA, Alsous M, Elayeh E, Hattab D. A cross-sectional study on knowledge and perceptions of pharmacovigilance among pharmacy students of selected tertiary institutions in Jordan. Tropical J Pharm Res. 2015;14:1899-1905. DOI: https://doi.org/10.4314/tjpr.v14i10.23
[46] Isfahani ME, Mousavi S, Rakhshan A, Assarian M, Kuti L, Eslami K. Adverse drug reactions: knowledge, attitude and practice of pharmacy students. J Pharm Care. 2013;1:145-148.
[47] Ahmad A, Khan MU, Moorthy J, Kumar BD, Kumar GS, Patel I. Comparison of knowledge, attitudes and perceived barriers towards adverse drug reactions reporting between bachelor of pharmacy and doctor of pharmacy students in southern India. J Pharma Health Serv Res. 2016;7:63-69. DOI: https://doi.org/10.1111/jphs.12128
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 International Journal of Computational and Experimental Science and Engineering
This work is licensed under a Creative Commons Attribution 4.0 International License.
